Home » Topics » Regulatory

Regulatory
RSS

Lev receives FDA approval for Cinryze in hereditary angioedema prophylaxis

Oct. 13, 2008

FDA approves Bayer HealthCare's Kogenate for prophylaxis in hemophilia A

Oct. 13, 2008

Santhera launches Catena in Canada for Friedreich's ataxia

Oct. 10, 2008

FDA approves Akten ophthalmic gel 3.5%

Oct. 9, 2008

European Commission adopts EMEA recommendations for Arcoxia 90 mg

Oct. 2, 2008

Aclasta approved in Europe for osteoporosis in men with high risk of fractures

Oct. 1, 2008

CHMP issues positive opinion for olanzapine long-acting injection in schizophrenia

Sep. 29, 2008

Xarelto approved in Canada for prevention of venous thromboembolic events

Sep. 17, 2008

FDA approves Gamunex for inflammatory demyelinating polyneuropathy

Sep. 17, 2008

Vimpat approved in the E.U. for partial-onset seizures

Sep. 3, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...